FDA committee recomends OraSure' OraQuick In-Home HIV Test
OraSure Technologies announced that the FDA Blood Products Advisory Committee provided a unanimous positive recommendation for the Company's OraQuick In-Home HIV Test. The BPAC provides advice to the FDA on issues related to the safety and effectiveness of biological products and medical devices seeking FDA approval. :theflyonthewall.com
FDA Blood Products Advisory Committee to host a meeting
The Committee discusses the evaluation of the safety and effectiveness of OraSure Technologies' OraQuick In-Home HIV Test for sale in the U.S. consumer over-the-counter (OTC) market in a meeting being held in Gaithersburg, Maryland on May 15 at 8:30 am. Webcast Link :theflyonthewall.com
Subscribe for More Information
